Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 6Gynecologic 4Gastrointestinal 3Other hematologic neoplasm 2Genitourinary 2Endocrine 2NET 1Classical hematology 1CNS 1

Conditions

Prostatic Neoplasms 1754Urinary Bladder Neoplasms 351Carcinoma, Renal Cell 217Breast Neoplasms 210Neoplasms 164Kidney Neoplasms 158Lung Neoplasms 101Colorectal Neoplasms 95Motor Activity 85Testicular Neoplasms 60Ovarian Neoplasms 53Colonic Neoplasms 48Melanoma 47Pancreatic Neoplasms 44Neoplasm Metastasis 43Non-Muscle Invasive Bladder Neoplasms 42Urinary Incontinence 40Head and Neck Neoplasms 40Uterine Cervical Neoplasms 39Disease 39Carcinoma, Transitional Cell 39Sarcoma 37Urologic Neoplasms 36Recurrence 35Anxiety Disorders 32Stomach Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Lymphoma 28Endometrial Neoplasms 28Prostatic Hyperplasia 27

Interventions

Multiparametric Magnetic Resonance Imaging 1Exome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Genetic Predisposition to Disease × Genitourinary × Clear all
NCT07416812 2026-02-18

IMPACT

Institute of Oncology Ljubljana

Phase NA Completed
25 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT05681416 2023-01-12

ProFam-Risk

Heinrich-Heine University, Duesseldorf

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡